The SPINT2 gene has been proposed to act as a putative tumor suppressor in several cancer entities, including gastric cancer (45), glioblastoma (46), medulloblastoma (47), melanoma (48), and renal cell carcinoma (49). This evidence concerns the gene SPINT2 and hereditary clear cell renal cell carcinoma.